Matthew J. Wyvratt
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Synthesis and Biological Evaluation, Growth Hormone and Insulin-like Growth Factors, Pharmacological Effects and Assays, Signaling Pathways in Disease
Most-Cited Works
- → (2R)-4-Oxo-4-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin- 7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: A Potent, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes(2004)814 cited
- → A new class of angiotensin-converting enzyme inhibitors(1980)706 cited
- → Peptidomimetic Regulation of Growth Hormone Secretion(1997)524 cited
- → A Nonpeptidyl Growth Hormone Secretagogue(1993)348 cited
- → Recent developments in the design of angiotensin‐converting enzyme inhibitors(1985)254 cited
- → The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin.(1992)253 cited
- → Human β3-adrenergic receptor agonists containing 1,2,3-triazole-substituted benzenesulfonamides(2000)199 cited
- → Pyrazoleamide compounds are potent antimalarials that target Na+ homeostasis in intraerythrocytic Plasmodium falciparum(2014)131 cited
- Modulation of pulsatile GH release through a novel receptor in hypothalamus and pituitary gland.(1996)
- → A Novel 3-Substituted Benzazepinone Growth Hormone Secretagogue (L-692,429)(1994)101 cited